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The different extracts of Oncoba spinosa (Flacourtiaceae) 
were screened for in vitro antidiabetic activity. Of all the extracts 
tested, ethanolic extract showed highest α-amylase inhibition 
ranging from 8.64+0.66% to 79.94+0.65% and α-glucosidase 
inhibition ranging from 14.12+0.51% to 78.68+0.36% when 
studied at concentrations 62.5-1000μg/mL. The ethanolic extract 
was subjected to antidiarrheal activity and diarrheal severity was 
reduced significantly by 15.81% in 100mg/kg group, 30.45% in 
200mg/kg group and 74.37% in 400mg/kg group in castor oil 
induced diarrhea model. In castor oil induced enteropooling, the 
extract at doses 200mg/kg and 400mg/kg showed 33.46% and 
42.44% inhibition of intestinal accumulation. In the charcoal meal 
test, the distance travelled by charcoal meal was significantly 
reduced by the extract at doses 200mg/kg and 400mg/kg 
(P<0.01). The overall results tend to suggest the antidiabetic and 
antidiarrheal activities of Oncoba spinosa. 
 




Diabetes mellitus is a group of 
heterogenous disorders characterised by 
chronic hyperglycaemia mainly due to absolute 
(type 1 insulin-dependent) or relative (type 2 
noninsulin-dependent) deficiency of insulin 
hormone.  By 2030, the worldwide estimation 
of diabetic patients is likely to be more than 
double from that of 2005 without any 
intervention (Gershell 2005). Every year,           
about 5% of the deaths worldwide are likely 
related to diabetes (Hiremath et al., 2010). 
Diarrheal diseases are one of the leading causes 
of morbidity and mortality in developing 
countries and are responsible for the death of 
millions of people every year (Carlos et al., 
1990). Despite immense technological 
advancement in modern medicine, many people 
in the developing countries still rely on the 
healing practices and medicinal plants for their 
daily health care needs (Ojewole 2008). 
Therefore, the World Health Organization 
encouraged studies for the treatment and 
prevention of diarrheal diseases and diabetes 
treatment depending on traditional medical 
practices (Atta et al., 2004). 
Oncoba spinosa , the snuff-box tree, fried 
egg tree or fried-egg flower, is a spiny shrub 
that belongs to Flacourtiaceae which has 95 
genera and 800-1000 species. The leaves are 
dark, glossy green in colour and somewhat 
leathery and hairless. The fruits are grown up to 
60 mm in diameter, it consists of hard shell that 
becomes dark-reddish brown when mature 
with shiny seeds embedded in a dry yellowish 
pulp (Burkil 1984). Fruits and leaves are used 
for colds, fever, female infertility; seed oil as 
febrifuge. Traditionally the plant is used in the 
treatment of diabetes and tumour. The roots of 
Oncoba spinosa are used in the treatment of 
dysentery and bladder complaints (Burkil 1994). 
To the best of our knowledge, no reports were 
available on the antidiarrheal activity and 
antidiabetic activity of Oncoba spinosa roots. The 
aim of the present work was to study and 
evaluate the biological activity of roots of 
Oncoba spinosa as an α-glucosidase inhibitor, an 
α-amylase inhibitor, and an antidiarrheal. 
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MATERIALS AND METHOD 
Collection and identification of the plant 
materials 
Fresh roots of Oncoba spinosa were 
collected from Tirupathi, Andhrapradhesh. The 
plant was identified and authenticated 
taxonomically by Assistant professor K. 
Madhava chetty of the Department of Botany, 
S.V.University, Tirupathi, Andhra Pradesh, 
India. A voucher specimen of the collected 
sample was deposited in the herbarium of the 
institution for future reference. 
 
Preparation of the extract 
The roots are shade dried, made into 
coarse powder and extraction was done by 
using cold maceration process for 72h 
successively by using petroleum ether, 
chloroform, ethylacetate and ethanol and 
filtered to get extracts of respective solvents. 
All the extracts were vaccum dried to obtain 
chloroform extract (CEOS), ethylacetate extract 
(EAOS) and ethanol extract (EEOS) 
respectively. The ethanolic extract was 




Albino wistar rats (weighing between 
150-200g) of both sexes were selected for the 
antidiarrheal studies. They had free access to 
food and water and were maintained under 
standard laboratory conditions which included 
12h light-dark cycle and temperature of 28-30 
degrees centigrade. Animals are allowed for a 
one week of acclimatization period prior to the 
study. The experimental protocol was approved 
by the IAEC (institutional animal ethical 
committee) and care of the experimental 
animals was taken according to the CPCSEA 
guidelines. 
 
In-vitro α-amylase inhibition assay 
One hundred micro liter of the test 
extract was allowed to react with 200μL of           
α-amylase enzyme and 100μL of 2mM of 
phosphate buffer (pH-6.9). After 20min 
incubation, 100μL of 1% starch solution was 
added. The same was performed for the 
controls where 100μL of the test extract was 
replaced by buffer. After incubation for 5min, 
500μL of dinitrosalicylic acid reagent was added 
to both control and test. They were kept in 
boiling water bath for 5 min. The absorbance 
was recorded at 540nm using spectro-
photometer and the percentage inhibition of α-
amylase enzyme was calculated using the below 
formula. Acarbose was used as positive control.  
Inhibition (%) = 100 ( 
Control – Test  
) 
Control 
Suitable reagent blank and inhibitor controls 
were simultaneously carried out. 
Concentrations of extracts resulting in 
50% inhibition of enzyme activity (IC50) were 
determined graphically (Bernfeld, 1955). 
 
In-vitro α-glucosidase assay 
A volume of 60μL of sample solution 
and 50μL of 0.1M phosphate buffer (pH 6.8) 
containing α-glucosidase solution (0.2U/mL) 
was incubated at 37ºC for 20min. After pre-
incubation, 50μL of 5mM p-nitrophenyl-α-D-
glucopyranoside (PNPG) solution in 0.1M 
phosphate buffer (pH 6.8) was added and 
incubated at 37ºC for another 20min. Then               
the reaction was stopped by adding 160μL of 
0.2M Na2CO3, and absorbance readings were 
recorded at 405nm and compared to a control 
which had 60μL of buffer solution in place             
of the extract. For blank incubation (to allow 
for absorbance produced by the extract), 
enzyme solution was replaced by buffer 
solution and absorbance recorded. The α-
glucosidase inhibitory activity was expressed as 
inhibition %. Acarbose was used as positive 
control (Kaskoos 2013). 
 
Inhibition (%)= 100 ( 
Control – Test  
) 
Control 
Concentrations of extracts resulting in 50% 
inhibition of enzyme activity (IC50) were 
determined graphically. 
 
Castor oil induced diarrhea 
Rats selected for the experiment are 
fasted for 18h with only access to water are 
divided into five groups of six animals each. 
Group I received vehicle 1% CMC, group II 
received 100mg/kg of EEOS orally, group III 
received 200mg/kg of EEOS orally, group IV 
received 400mg/kg of EEOS orally and group 
V received atropine 3mg/kg i.p. After 1h of 
treatment with the extract, standard drug and 
vehicle, 1mL of castor oil was given orally to all  
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the five groups of animals. The rats were then 
placed in metabolic cages and the floor of the 
cages was lined with adsorbent papers in order 
to collect the faeces.  All the animals are to be 
observed for four hours for the presence of 
diarrhea (Shoba et al., 2001; Ujjin et al., 2005).  
Antidiarrheal activity of the drug or 
extract was expressed in terms of percent 
inhibition of diarrhea. The percent inhibition of 
defecation was calculated by using the formula: 




X is the mean number of defecation caused by 
castor oil and Y is the mean number of 
defecation caused by drug or extract. 
 
Castor oil induced enteropooling 
Rats selected for the experiment are 
fasted for 18 hours with only access to water 
are divided into five groups of six animals each. 
Group I received vehicle 1% CMC, group II 
received 100mg/kg of EEOS orally, group III 
received 200mg/kg of EEOS orally, group IV 
received 400mg/kg of EEOS orally and group 
V received atropine 3mg/kg i.p. After 1 hour of 
treatment with the extract, standard drug and 
vehicle, 1mL of castor oil was given orally to all 
the five groups of animals. After 1h of 
treatment with castor oil, rats from all the 
groups were sacrificed and whole intestine 
from the pylorus to caecum was removed after 
tying the ends with thread and weighed. The 
contents of the intestine were collected by 
milking into a graduated tube. The intestine was 
reweighed and the difference between the full 
and empty intestine was measured in grams 
(Robert et al., 1976). 
 
Percentage of  





Tc: :Mean fluid accumulation in control group 
and Tt :Mean fluid accumulation in test group 
 
Charcoal meal test or gastrointestinal 
motility test 
Rats selected for the experiment are 
fasted for 18h with only access to water are 
divided into five groups of six animals each. 
Group I received vehicle 1% CMC, group II 
received 100mg/kg of EEOS orally, group III 
received 200mg/kg of EEOS orally, group IV 
received 400mg/kg of EEOS orally and group 
V received atropine 3mg/kg i.p. After 1h of 
treatment with the extract, standard drug and 
vehicle, 1mL of castor oil was given orally to all 
the five groups of animals. After 1h of 
treatment with castor oil, 1mL of marker (10% 
charcoal suspension in 5% gum acacia) was 
administered orally to all the animals in all the 
five groups. The rats were sacrificed after one 
hour and the small intestine was removed 
surgically and the distance travelled by the 
charcoal meal from pylorus to caecum was 
measured after keeping the intestine on a clean 
transparent clean glass and the values are 
expressed as percentage with respect to the 
total length of the intestine from pylorus to 
caecum (Mascolo et al., 1994). The percentage 
of inhibition was also calculated by using the 
following formula (Mujumdar 1998). 
 
Distance  
travelled (%) = 
Distance travelled by 




(%) =  
Total length-Distance 




Results are expressed as mean±SEM. 
Data obtained was analyzed by using one way 
ANOVA followed by Dunnett’s test and 
p<0.05 was considered as statistically 
significant. 
 
RESULTS AND DISCUSSION 
Preliminary phytochemical analysis 
Results obtained for qualitative screening 
of phytochemicals in roots of Oncoba spinosaare 
presented in table I. 
 
In-vitro α-amylase inhibition assay 
The α-amylase inhibitory effect of CEOS 
was found to be ranging from 3.61±0.42%           
to 26.80±0.58%. The α-amylase inhibitory 
effect of EAOS was found to be ranging          
from 5.91+0.56% to 61.18+0.17% when 
studied at concentrations 62.5-1000μg/mL.           
At same concentration, the inhibitory effect           
of EEOS was found to be ranging              
from 8.64+0.66% to 79.94+0.65% whereas               
the effect of the standard drug acarbose,  
ranged   from   18.54+0.31%  to  82.73+0.65%.  
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The IC50 value of ethylacetate extract,           
EAOS was found to be 589.32μg/mL whereas 
the ethanolic extract, EEOS showed at 
308.19μg/mL. The IC50 of acarbose was found 
to be 246.90μg/mL (Table II). 
 
In vitro α-glucosidase inhibition assay 
The α-glucosidase inhibitory effect of 
CEOS was found to be ranging from 
2.98±0.26% to 29.29±0.44%. The α-
glucosidase inhibitory effect of EAOS was 
found to be ranging from 6.43+0.01% to 
55.21+0.28% when studied at concentrations 
62.5-1000μg/mL. At same concentration, the 
inhibitory effect of EEOS was found to be 
ranging from 14.12+0.51% to 78.68+0.36% 
whereas the effect of the standard drug 
acarbose, ranged from 19.92+0.39 to 
82.50+0.39%. The IC50 value of ethylacetate 
extract,  EAOS  was found to be     914.98μg/mL  
whereas the ethanolic extract, EEOS showed at 
300.39μg/mL. The IC50 of acarbose was found 
to be 251.89μg/mL (Table III). 
 
Castor oil-induced diarrhea 
In castor-oil induced diarrhea, EEOS 
was found to be effective in a dose dependent 
manner against castor oil induced diarrhea. The 
effect of EEOS at the dose levels of 100, 200 
and 400 mg/kg caused a dose dependent 
decrease in the number of faecal matter from 
25.33, 18.16 and 8.16 respectively.  However, 
percent reduction in total number of faecal 
matter ranges from 16.95 to 73.24%. EEOS at 
100 mg/kg showed 15.81% inhibition of 
diarrhea whereas doses 200mg/kg and 400 
mg/kg showed 30.45% and 74.37% inhibition 
respectively. The standard drug atropine 
showed 80.52% inhibition of diarrhea. The 
results are shown in table IV. 
 
Table I. Qualitative phytochemical analysis of O. spinosa roots 
 
 
S.No Chemical Constituent CEOS EAOS EEOS 
1 Alkaloids - - - 
2 Carbohydrates - + + 
3 Glycosides - + + 
4 Anthroquinones - - - 
5 Cardiac glycosides - - - 
6 Saponins - - + 
7 Steroids + - - 
8 Phenols - + + 
9 Tannins - + + 
10 Proteins - + + 
11 Terpenoids - - - 
12 Flavonoids - + + 
 
Note: + ve indicates presence, whereas  – ve indicates absence. CEOS: Chloroform extract of Oncoba spinosa, 
EAOS: ethyl acetate extract of Oncoba Spinosa and EEOS: ethanol extract of  Oncoba spinosa 
 





% Inhibition Concentration (μg/mL) 
IC50(μg/mL) 
62.5μg/mL  125μg/mL 250μg/mL 500μg/mL 1000μg/mL 
CEOS 3.61±0.42 8.07±0.62 12.81±0.46 16.88±0.48 26.80±0.58 >1000μg/mL 
EAOS 5.91±0.56 16.36±0.36 31.04±0.57 47.55±0.20 61.18±0.17 589.32μg/mL 
EEOS 8.64±0.66 20.72±1.15 41.43±0.99 69.90±0.47 79.94±0.65 308.19μg/mL 
Acarbose 
(Standard) 
18.54±0.31 29.30±0.25 48.05±0.67 72.61±0.25 82.73±0.65 246.90μg/mL 
 
CEOS=chloroform extract of Oncoba spinosa; EAOS=ethylacetate extract of Oncoba spinosa, EEOS=ethanol extract of 
Oncoba Spinosa. Values are expressed as mean±SEM of triplicate measurement 
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Castor oil-induced enteropooling 
EEOS showed a significant reduction in 
castor oil-induced fluid accumulation at 
200mg/kg and 400mg/kg with respective 
values of 1.63±0.20 (p<0.05) and 1.41±0.13 
(p<0.01). Atropine significantly reduced 
(p<0.01) the fluid accumulation with value of 
0.71±0.13 at the dose of 3mg/kg. EEOS 
reduced the castor oil induced intraluminal 
accumulation of fluid by 8.97, 33.46 and 
42.44% at doses of 100, 200 and 400mg/kg 
respectively. Results are shown in table V. 
Charcoal meal test 
In charcoal meal test, the extract at 
100mg/kg dose did not show any significant 
reduction in the distance travelled by the 
charcoal meal when compared to the castor oil 
control group. The gastrointestinal distance 
travelled by the charcoal meal in the rats 
significantly reduced by the extract at the doses 
200mg/kg and 400mg/kg (P<0.01). In charcoal 
meal test, the percent inhibition of charcoal 
meal was found to be 8.94±1.23 in control 
group,  13.26±2.51  in  100mg/kg  dose  group,  




%Inhibition Concentration (μg/mL) IC50 
(μg/mL) 62.5μg/mL  125μg/mL 250μg/mL 500 μg/mL 1000 μg/mL 
CEOS 2.98±0.26 5.94±0.44 13.97±0.32 22.63±0.08 29.29±0.44 >1000μg/mL 
EAOS 6.43±0.01 11.98±0.48 21.79±0.23 37.03±0.12 55.21±0.28 914.98μg/mL 
EEOS 14.12±0.51 26.68±0.49 41.79±0.13 66.09±0.32 78.68±0.36 300.39μg/mL 
Acarbose 
(Standard) 
19.92±0.39 33.23±0.28 46.40±0.53 66.70±0.32 82.50±0.39 251.89μg/mL 
 
CEOS=chloroform extract of Oncoba spinosa; EAOS=ethylacetate extract of Oncoba spinosa, EEOS=ethanol 
extract of Oncoba spinosa. Values are expressed as mean±SEM of triplicate measurement 
 













castor oil 1mL 
30.50±2.14 - 13.66±0.84 - 
EEOS-100mg/kg 25.33±1.94 16.95   11.50±0.42* 15.81 
EEOS-200mg/kg     18.16±1.30** 40.45       9.50±0.61** 30.45 
EEOS-400mg/kg      8.16±0.54** 73.24       3.50±0.42** 74.37 
Atropine-3 mg/kg      4.66±0.61** 84.72       2.66±0.33** 80.52 
 
Values are expressed as mean±SEM (n=6 in each group).  *P<0.05 and **P<0.01 when compared to castor 
oil control group. 
 




Weight of the 
intestinal content (g) 




castor oil 1mL 
6.10±0.58 2.45±0.33 - 
EEOS-100mg/kg 5.93±0.16ns   2.23±0.16ns 8.97 
EEOS-200mg/kg 4.48±0.33*   1.63±0.20* 33.46 
EEOS-400mg/kg  2.33±0.26**    1.41±0.13** 42.44 
Atropine-3mg/kg  1.50±0.10**   0.71 ±0.13** 71.02 
 
Values are expressed as mean±SEM (n=6 in each group). *P<0.05 and **P<0.01 when compared 
to castor oil control group. 
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47.81±2.42 in 200mg/kg dose group (p<0.01), 
53.61±2.31 in 400 mg/kg dose group (p<0.01) 
and 73.16±1.52 in standard group (p<0.01). 
Results are shown in table VI. 
Hyperglycemia has been a classical risk 
in the development of diabetes and the 
complications associated with diabetes. 
Therefore control of blood glucose levels is 
critical in the early treatment of diabetes 
mellitus and reduction of macro- and 
microvascular complications. One therapeutic 
approach is the prevention of carbohydrate 
absorption after food intake, which is facilitated 
by inhibition of enteric enzymes including α-
glucosidase and α-amylase present in the brush 
borders of intestine. In this study, the α-
amylase and α-glucosidase inhibitory activity of 
the roots of Oncoba spinosa was investigated. The 
inhibitory effect of CEOS, EAOS, and EEOS 
were analysed. Alpha amylase converts starch 
to maltose which reduces 3,5-dinitrosalicylic 
acid to 3-amino-5-nitrosalicylic acid. Inhibition 
of α-amylase resulted in a decreased production 
of maltose. This maltose will reduce the 3,5-
dinitrosalicylic acid in the colouring agent to 3-
amino-5-nitrosalicylic acid. This reaction will 
produce a colour change from orange to red.  
Starch + H2O+ α-amylase -->Maltose (red 
colour) 
The intensity of red colour will be 
directly proportional to the amount of maltose 
produced. When an enzyme inhibitor is present 
in the reaction mixture, digestion of starch, 
production of maltose and intensity of red 
colour produced will be less (Rao et al., 2008). 
α--glucosidase will catalyze the conversion of 
the substrate 4-nitrophenyl-D-glucopyranoside 
to D-glucopyranoside and p-nitrophenol. The 
yellow colour of the latter product is measured 
spectrophotometrically at 405 nm. 
PNPG + α-glucosidase --> α-D-glucopyrano-
side + PNP (yellow colour) 
The intensity of the colour produced is 
directly proportional to extent of digestion of 
PNPG and released p-nitro phenol. Thus in the 
presence of an inhibitor, digestion of PNPG, 
production of p-nitro phenol and intensity of 
colour produced will be less (Subramanian et al., 
2008). Acarbose, a known α-amylase and α-
glucosidase inhibitor, currently used in 
antidiabetic therapy for reducing postprandial 
increase in blood glucose levels, reduced the 
intensity of the colour produced. The plant 
extracts (EAOS and EEOS) also produced 
decrease in colour intensities in both the in 
vitro assays suggesting that they also possess 
inhibitory potential against α-amylase and α-
glucosidase enzymes. Previous reports suggest 
that various potential inhibitors isolated from 
medicinal plants belong to flavonoid and 
glycoside class (Lee et al., 2008; Jong et al., 
2007). Based on the preliminary phytochemical 
analysis, we speculate that the presence of 
flavonoids and  glycosides might have contributed 
to the α-amylase and α-glucosidase inhibitory 
activity. 
 The ethanolic extract which showed 
highest α-amylase and α-glucosidase inhibition 
was selected for antidiarrheal activity. Castor oil 
increases volume of intestinal content by 
prevention of the re-absorption of water and 
the liberation of ricinoleic acid from castor oil 




Length of the 
intestine (cm) 
Distance travelled  
by the charcoal meal 
(cms) 
Distance travelled 




castor oil 1mL 
72.83±1.60 61.00 ±1.71 89.04 ±1.33 8.94 ±1.23 
EEOS-100mg/kg 63.33±1.43 56.00 ±1.12ns 83.72±1.11 13.26 ±2.51 ns 
EEOS-200mg/kg 68.66±1.10 35.00±1.50** 51.17 ±2.12** 47.81 ±2.42** 
EEOS-400mg/kg 65.66±2.46 23.00 ±1.25** 38.17 ±2.51** 53.61 ±2.31** 
Atropine-3mg/kg 69.12±2.12 16.00±1.32** 23.12 ±1.52** 73.16 ±1.52** 
 
Values are expressed as mean±SEM (n=6 in each group). **P<0.01 when compared to castor oil control 
group 
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results in irritation and inflammation of the 
intestinal mucosa leading to release of 
prostaglandins which results in stimulation of 
motility and secretion and the prevention of re-
absorption of NaCl and water (Das et al., 2007). 
This is characterized by an increase in the 
secretion of water and electrolytes, an increase 
in intestinal transit time and an increase in wet 
faeces (Oben et al., 2006). Our results showed 
that the extract inhibited significantly castor oil 
induced diarrhea in rats and the effect was 
almost similar to standard drug. The plant 
extract may have brought about this activity by 
re-absorption of water from the intestinal 
lumen or by anti prostaglandin activities that 
contribute to patho-physiological functions in 
the gastrointestinal tract. The results of our 
present study showed the extract at the doses 
200 mg/kg (p<0.05) and 400 mg/kg (p<0.01) 
significantly reduced the volume of intestinal 
fluid accumulation in rats. The prevention of 
intraluminal fluid secretion by Oncoba spinosa in 
this study may be due to inhibition of 
prostaglandin biosynthesis with resultant 
decrease in secretion of fluid into the lumen or 
may be due to promotion of absorption of 
water and electrolytes in the gut. In charcoal 
meal test, administration of EEOS in rats 
caused a significant reduction in the 
progression of charcoal meal and in the 
intestinal transit time. This activity is 
comparable to that of atropine used here as a 
reference drug and which is known to reduce 
the intestinal motility (longanga et al., 2000). 
The antidiarrheal effect of EEOS could thus 
result from a reduction of intestinal motility 
and an increase in the intestinal absorption of 
water and electrolytes. In fact, many previous 
studies have shown that drugs and natural 
products as well, can induce their antidiarrheal 
effect through antispasmodic activity (Rehman 
et al., 2009).  
Preliminary phytochemical analysis of 
ethanolic extract showed the presence of 
carbohydrates, glycosides, saponins, flavonoids, 
phenols, tannins and proteins. Previously 
various medicinal plants were screened for 
antidiarrheal activities and the activity is due to 
presence of tannins, alkaloids, saponins, 
flavonoids, steroids, terpenes and glycosides 
(Longanga et al., 2000). The presence of some 
of these phytochemical constituents in Oncoba 




In conclusion, the results of this 
investigation revealed that ethanolic extract of 
Oncoba spinosa contains pharmacologically active 
substances with antidiarrheal and antidiabetic 
properties. These attributes may provide the 
rationale for the use of Oncoba spinosa in 
traditional medicine for the treatment of 
diarrhea and diabetes. Further research is 
needed to fractionate the ethanolic extract and 
isolate the molecule(s) responsible for the 
antidiarrheal and antidiabetic activity. 
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